These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23288118)

  • 21. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
    Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
    Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-drug resistant tuberculosis in Northern Pakistan.
    Butt T; Ahmad RN; Kazmi SY; Rafi N
    J Pak Med Assoc; 2004 Sep; 54(9):469-72. PubMed ID: 15518370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh.
    Zaman K; Rahim Z; Yunus M; Arifeen S; Baqui A; Sack D; Hossain S; Banu S; Islam MA; Ahmed J; Breiman R; Black R
    Scand J Infect Dis; 2005; 37(1):21-6. PubMed ID: 15764186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary bacillary resistance in multidrug-resistant tuberculosis and predictive factors associated with cure at a referral center in São Paulo, Brazil.
    Savioli MTG; Morrone N; Santoro I
    J Bras Pneumol; 2019 Mar; 45(2):e20180075. PubMed ID: 30864608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of drug-resistant Mycobacterium tuberculosis in patients under intermittent or daily treatment.
    Alvarez TA; Rodrigues MP; Viegas CA
    J Bras Pneumol; 2009 Jun; 35(6):555-60. PubMed ID: 19618036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and genetic determinant of drug-resistant tuberculosis among patients completing intensive phase of treatment in a Tertiary Referral Center in Nigeria.
    Mohammad AB; Iliyasu G; Habib AG
    Int J Mycobacteriol; 2017; 6(1):47-51. PubMed ID: 28317805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
    Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.
    Dalcolmo M; Gayoso R; Sotgiu G; D'Ambrosio L; Rocha JL; Borga L; Fandinho F; Braga JU; Arakaki Sanchez D; Dockhorn F; Centis R; Migliori GB
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404651
    [No Abstract]   [Full Text] [Related]  

  • 30. High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
    Chen L; Li N; Liu M; Zhang J; Zhang H
    J Antimicrob Chemother; 2011 Oct; 66(10):2435-7. PubMed ID: 21795258
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycobacterium tuberculosis Complex Drug Resistance in a High Tuberculosis Incidence Area from the WHO Eastern Mediterranean Region.
    Mansoori N; Douraghi M; Rajabloo AA; Taziki M; Yaseri M; Vaziri F
    J Pharm Pharm Sci; 2017; 20(1):428-434. PubMed ID: 29197427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
    Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
    BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran.
    Mirsaeidi MS; Tabarsi P; Farnia P; Ebrahimi G; Morris MW; Masjedi MR; Velayati AA; Mansouri D
    Saudi Med J; 2007 Apr; 28(4):544-50. PubMed ID: 17457475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium tuberculosis complex strains and drug susceptibility in a cattle-rearing region of Cameroon.
    Kuaban C; Um Boock A; Noeske J; Bekang F; Eyangoh S
    Int J Tuberc Lung Dis; 2014 Jan; 18(1):34-8. PubMed ID: 24365549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical predictors of drug-resistant tuberculosis in three clinical settings in Calabar, Nigeria.
    Otu A; Umoh V; Habib A; Ansa V
    Clin Respir J; 2014 Apr; 8(2):234-9. PubMed ID: 24131513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome.
    Surucuoglu S; Ozkutuk N; Celik P; Gazi H; Dinc G; Kurutepe S; Koroglu G; Havlucu Y; Tuncay G
    Ann Saudi Med; 2005; 25(4):313-8. PubMed ID: 16212125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya.
    Kerubo G; Amukoye E; Niemann S; Kariuki S
    BMC Infect Dis; 2016 Oct; 16(1):583. PubMed ID: 27756241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.